4 HEALTH INNOVATION NORGE AS: årsregnskap 2013 vs 2012
Mixed movements in the accounts
approved 2014-05-30; registry 2014-09-03; journal 2014 756351
Summary
What changed
Comparing Årsregnskap 2013 with 2012 for 4 HEALTH INNOVATION NORGE AS. Revenue 0 NOK → 186.5k NOK. Equity -52.9k NOK → -195.5k NOK.
On the constructive side: revenue rose. Pressures included: equity eroded.
Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 4 HEALTH INNOVATION NORGE AS.
At a glance
Scorecard
Revenue
0 NOK
186.5k NOK
—
Operating result
n/m
-106.5k NOK
—
Equity
-52.9k NOK
-195.5k NOK
-269.3%
Cash
0 NOK
0 NOK
0.0%
Total assets
34.4k NOK
4 633 NOK
-86.5%
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 186.5k NOK. Calculated
What deteriorated
-
↓
Equity eroded
Book equity -52.9k NOK → -195.5k NOK (equity ratio -154.1% → -4220.0%). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -4220.0% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation